Approval · Notice of Compliance 16565 · 2015
PHEBURANE: Notice of Compliance 16565
Issued January 26, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16565
- Date
- January 26, 2015
- Company
- Medunik CanadaBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Alimentary tract and metabolism product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHEBURANE | 02436663 | Marketed |
Medicinal ingredients
- SODIUM PHENYLBUTYRATE 483 MG per G